AngioDynamics (ANGO) Misses Q4 EPS by 1c, Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- AI stocks lift Wall St as oil falls, Treasury yields decline
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- AMD stock jumps as chip rally builds ahead of summit
- Novo Nordisk shares drop as investor event disappoints
AngioDynamics Reports Fiscal 2018 Fourth Quarter and Full-Year Financial Results
July 11, 2018 7:00 AM EDTFiscal 2018 Fourth Quarter Highlights
Net sales of $88.3 million, an increase of 1.6% year over year Gross margin expanded 500 basis points year over year to 53.7% GAAP EPS of $0.06 per share; adjusted EPS of $0.20 per share Operating cash flow of $23.8 million; free cash flow of $23.0 millionFull-Year 2018 Highlights
Net sales of $344.3 million, a decrease of 1.5% year over year Gross margin expanded 100 basis points year over year to 51.4%... More